As of late 2024 and into 2025, the medical community is at an inflection point. The ESC Guidelines still favor CHA₂DS₂-VASc, but the ABC2D score is gaining traction for three reasons:
Recent studies and external validations indicate the score's diagnostic utility: Optimal Cutoff : A score of is typically used to predict ICAS-O. Sensitivity and Specificity abc2d score
trial fibrillation (Absence of AF generally favors an atherosclerotic cause). As of late 2024 and into 2025, the
: The ABC2D score suggests that the net clinical benefit for anticoagulation begins at a score ≥ 2 . This aligns with the mantra: "ABC2D of 2, anticoagulate for you." anticoagulate for you."